Please login to the form below

Not currently logged in
Email:
Password:

Biomarker

This page shows the latest Biomarker news and features for those working in and with pharma, biotech and healthcare.

Sarepta bounces back with new gene therapy data

Sarepta bounces back with new gene therapy data

The levels of creative kinase were also significantly reduced – this enzyme biomarker is associated with muscle damage in people with the genetic disease.

Latest news

More from news
Approximately 5 fully matching, plus 274 partially matching documents found.

Latest Intelligence

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    The cancer immunotherapy firms ramping-up biomarker R&D. All indications suggest biomarkers could aid cancer immunotherapy development and help doctors predict therapeutic impact. But industry still has to agree harmonised ... The response has been a

  • A roadmap to the successful treatment of Alzheimer’s disease A roadmap to the successful treatment of Alzheimer’s disease

    Through this work, it may be possible to identify biomarkers that could lead to the development of preventive medicine for use in the wider Alzheimer’s population. ... This would create a similar situation to cardiovascular disease where we use

  • Rare disease trials Q&A Rare disease trials Q&A

    The selection of appropriate biomarkers and treatment outcomes. The design of clinical trials that can generate substantial efficacy and safety data and motivate patients.

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    Jean Georges Executive Director of Alzheimer Europe: “Preventing the development of dementia in biomarker-positive people would be a fantastic step forward in our fight against Alzheimer’s disease.

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    However, the therapy wasn’t able to show an impact on biomarkers used to gauge the efficacy of MPS II drugs, and the company is now suggesting that it will have

More from intelligence
Approximately 2 fully matching, plus 41 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

  • Diagnosing the lag in neuropsychiatric treatments

    The answer is simple, while bacterial and viral infections could be distinguished through characteristic biomarkers, reliable biomarkers for psychiatric diseases are almost non-existent.

  • Navigating the antibiotic resistance crisis

    Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating this complex landscape.

  • Three key development areas in the management of multiple sclerosis

    Mark and Fabrice identified three key themes across the meeting:. The use of neurofilament light chain (NfL) levels as a biomarker for disease activity and response to treatment– when neurons or ... Research presented at ECTRIMS shows promise for NfL

  • A4P Bio Consulting Ltd

    As experts in biomarkers, bioanalysis, pharmacokinetics, logistics and quality systems management A4P deliver scientifically robust, regulatory compliant, cost effective and value added solutions for the global life sciences sector.

  • Is the pharma business model ready for precision medicine?

    It exists at the convergence of genomic sequencing, biomarker research, bioinformatics and big data analysis. ... This differs from traditional tumour type or ‘adaptive’ trials where the predictive biomarker is not clearly identified at trial

More from PMHub
Approximately 5 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics